Navigation Links
VNS Therapy System

ProductsVNS Therapy System
Company Cyberonics, Inc.
Item VNS Therapy System
Features 
  • Implantable, pacemaker-like, multiprogrammable, pulse generator and lead
  • Delivers mild, preprogrammed intermittent electrical pulses to the left vagus nerve which sends signals to the brain
  • Magnet use allows patient/caregiver on-demand stimulation
  • Simple in-office programming
  • Assured compliance
  • Description Since 1997, VNS Therapy has been approved for use as an adjunctive therapy in reducing the frequency of seizures in adults and adolescents over 12 years of age with partial onset seizures that are refractory to antiepileptic medications. This indication is based on outcomes from 5 controlled, clinical trials. Efficacy, measured as median seizure reduction, was observed in these clinical trials and other study populations. VNS Therapy resulted in median reductions in seizures of 31.3%, 40.7%, and 40.4% at 1, 2, and 3 years, respectively.1 Moreover, VNS Therapy offers a unique and favorable side effect profile that avoids cerebral toxicity.2

    Quality-of-life improvements have also been observed in patients using VNS Therapy. Long-term continuation rates suggest that many patients are satisfied with VNS Therapy. More specifically, some recent publications have demonstrated evidence of quality-of-life improvements observed with VNS Therapy. Alertness, daytime sleepiness, mood, and memory have shown improvement in VNS Therapy patients.

    VNS Therapy delivers stimulation via a device implanted just under the skin in the left chest area. The pacemaker-like device sends mild, intermittent electrical impulses through a lead to the left vagus nerve, which then sends signals to the brain. Each device is programmed for the individual patient, and the patient or a caregiver has the ability to initiate or abort stimulation with the use of a hand-held magnet.
    Info Cyberonics, Inc.
    Customer Service: (888) 867-7846
    Web site: http://www.cyberonics.com/

    Related medicine products :

    1. Activa Therapy System
    2. VISULAS 690s Photodynamic Therapy Laser System
    3. Cold Shoulder™ Therapy Wrap
    4. InterStim Therapy -- Sacral Nerve Stimulation (SNS) for Urinary Control
    5. Osbon ErecAid Vacuum Therapy System - Automatic
    6. Osbon ErecAid Vacuum Therapy System - Manual
    7. Osbon ErecAid Vacuum Therapy System - Classic
    8. ErecAid® Esteem™ External Vacuum Therapy System
    9. Sanford Guide to HIV/AIDS Therapy 2004
    10. Sanford Guide to Antimicrobial Therapy 2005
    11. Urostym™ Behaviorial Therapy System
    The Osteomark NTx Point of Care (POC)device allows physicians to monitor their patients response to anti-resorptive drugs as early as 3-6 months from starting treatment. Osteomark NTx shows you and y...
    ... 50 analyzer is an ... offices and smaller laboratories ... of state-of-the-art instrument-based testing ... efficient way to obtain ...
    ... Hemoglobin Test Systems provide ... quantitative hemoglobin results with ... a large hematology analyzer. ... of either the B-Hemoglobin ...
    ... a qualitative immunoassay for urinary albumin that ... This albumin specific, CLIA Waived test has ... of 95%, and gives accurate results in ... up to 8 hours. Since early detection ...
    Medicine Products:
    (Date:8/28/2014)... Hastings and Hastings, a Phoenix Arizona ... in the industry is pleased to report having saved ... approximately $125,000. This is exciting news for existing clients ... well defined proof that Hastings and Hastings stands behind ... fees. Saving clients money when it comes to settlements ...
    (Date:8/28/2014)... 28, 2014 InventHelp, a ... clients, an inventor from California, has designed an alternative ... invention is patented. , The “Abdominal Swimming Support” is ... risk of injuries from physical activity if one is ... or muscular atrophy. Ideal for use as a ...
    (Date:8/28/2014)... Baltimore, MD (PRWEB) August 28, 2014 ... has received Diamond level Allergan Privilege Program status ... widely used treatments as Botox, Juvederm, and Voluma. Maryland ... exemplary and prolific use of these treatments. The dermatologists ... in injectable treatments, and are one of the leading ...
    (Date:8/28/2014)... 2014 Altec Products, Inc., a ... announced today that they have been awarded the ... of the International Association of Microsoft Channel Partners ... founded in 1994, providing Microsoft Partners with a ... community at large while facilitating mutual growth and ...
    (Date:8/28/2014)... 2014 Dr. Bryan McIntosh of Bellevue, ... guide to the tummy tuck cosmetic procedure, leading ... procedure itself, and how to recover well afterwards. ... Dr. McIntosh also discusses how to have accurate expectations ... the procedure is as successful as possible. , To ...
    Breaking Medicine News(10 mins):Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $13,750 On A Settlement Of $125,000 2Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $13,750 On A Settlement Of $125,000 3Health News:InventHelp® Client Patents “Abdominal Swimming Support” – Invention Could Serve as an Alternative Flotation Device 2Health News:Maryland Laser Skin and Vein Receives Diamond Status From Allergan 2Health News:Altec and Bond Consulting Services Receive Award from the International Association of Microsoft Channel Partners SoCal Chapter 2Health News:Altec and Bond Consulting Services Receive Award from the International Association of Microsoft Channel Partners SoCal Chapter 3Health News:The Ultimate Guide to the Tummy Tuck Surgery eBook is Released by Dr. Bryan McIntosh 2
    ... healthy lifestyle that includes not smoking, limiting alcohol intake, and ... the journal PLoS Medicine , Wei Zheng, M.D., Ph.D., ... results from a large study quantifying the impact of combining ... lifestyle pattern being normal weight, having low belly fat, ...
    ... study released today by the American Lung Association, and ... helping smokers quit not only saves lives but also ... titled Smoking Cessation: the Economic Benefits, provides a nationwide ... smoking with the economic benefits of states providing cessation ...
    ... New research findings from the Universit de Montral reveals ... understand and use irony. This study, published recently in ... way parents communicate with their family. "Previous studies ... eight or ten," says Stephanie Alexander, a postdoctoral student ...
    ... really takes for seniors to make ends meet in each ... state Capitol in Sacramento. The release is ... (Elder Index), a tool that measures the actual costs of ... replacing federal poverty level (FPL) guidelines as a new standard ...
    ... HealthDay Reporter , TUESDAY, Sept. 14 (HealthDay News) ... when in vitro fertilization is done during the springtime. ... highest in the spring -- 73.5 percent vs. 67.9 ... than the summer and fall rates. "Epidemiolgists have ...
    ... TUESDAY, Sept. 14 (HealthDay News) -- The risk of tendon ... higher levels of estrogen, a small European study suggests. ... to test estrogen levels in order to identify at-risk athletes ... training program, said Katherine E. Burgess, of the University of ...
    Cached Medicine News:Health News:Benefits of healthy lifestyle factors stronger in combination 2Health News:New study finds positive return on investment for states that invest in quit smoking treatments 2Health News:New study finds positive return on investment for states that invest in quit smoking treatments 3Health News:Report shows federal poverty guidelines leave state's seniors destitute 2Health News:Report shows federal poverty guidelines leave state's seniors destitute 3Health News: In Vitro Fertilization Success Rate Higher in Spring, Study Suggests 2Health News: In Vitro Fertilization Success Rate Higher in Spring, Study Suggests 3
    (Date:8/27/2014)... SHENZHEN, China, Aug. 28, 2014 China ... ("Nepstar" or the "Company"), a leading retail drugstore ... directly operated stores, today announced its unaudited financial ... Financial HighlightsFor the quarter ended June 30, ... RMB686.6 million (US$110.7 million) compared to RMB638.8 million in ...
    (Date:8/27/2014)... British Columbia and MENLO PARK, ... Pharmaceuticals, Inc. , (OTCQB: DMPI), developer of advanced ... company at the 16th Annual Rodman & Renshaw Global ... Co., LLC. The presentation will take place Tuesday, September 9th ... (4th floor) at the New York Palace Hotel in ...
    (Date:8/27/2014)... BURLINGTON, Mass. , Aug. 27, 2014 /PRNewswire/ ... six different specialties (medical oncology, hematology-oncology, rheumatology, gastroenterology, ... of clinical trials that a biosimilar has been ... which biosimilar product they choose to prescribe. ... Advisory Service report entitled Acceptance of ...
    Breaking Medicine Technology:China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 2China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 3China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 4China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 5China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 6China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 7China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 8China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 9China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 10China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2014 Financial Results 11DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 2DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 3DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference 4Surveyed Physicians Expect to Choose Between Future Biosimilars Based on Robustness and Number of Clinical Trials 2